$894 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 67 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 24.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXAS | Sell | EXACT SCIENCES CORP | $28,618,000 | +23.6% | 478,649 | -16.6% | 3.20% | +26.1% |
| TDOC | Sell | TELADOC INC | $27,459,000 | +5.3% | 473,029 | -26.9% | 3.07% | +7.4% |
| SRPT | Sell | SAREPTA THERAPEUTICS | $27,189,000 | +12.0% | 205,699 | -37.2% | 3.04% | +14.2% |
| COLL | Sell | COLLEGIUM PHARMACEUT | $26,548,000 | -16.0% | 1,113,133 | -10.0% | 2.97% | -14.3% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $24,540,000 | -23.9% | 260,505 | -34.5% | 2.74% | -22.4% |
| KTWO | Sell | K2M GROUP HOLDINGS | $21,393,000 | -7.6% | 950,787 | -22.1% | 2.39% | -5.7% |
| ABMD | Sell | ABIOMED INC | $18,516,000 | -17.2% | 45,266 | -41.1% | 2.07% | -15.5% |
| PFE | Sell | PFIZER INC | $17,789,000 | -37.7% | 490,325 | -39.0% | 1.99% | -36.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $17,009,000 | -39.9% | 140,180 | -36.6% | 1.90% | -38.7% |
| NVS | Sell | NOVARTIS AGsp adr | $16,970,000 | -40.9% | 224,646 | -36.8% | 1.90% | -39.8% |
| UNH | Sell | UNITEDHEALTH GRP INC | $15,156,000 | -23.2% | 61,775 | -33.0% | 1.69% | -21.7% |
| PRAH | Sell | PRA HEALTH SCIENCE | $13,870,000 | +11.0% | 148,560 | -1.3% | 1.55% | +13.3% |
| MDT | Sell | MEDTRONIC PLC | $12,653,000 | -29.8% | 147,800 | -34.2% | 1.42% | -28.4% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $11,740,000 | +18.3% | 144,700 | -8.2% | 1.31% | +20.7% |
| MDGL | Sell | MADRIGAL PHARMACEUTI | $10,670,000 | +80.4% | 38,149 | -24.7% | 1.19% | +83.8% |
| LLY | Sell | ELI LILLY & CO | $10,461,000 | -25.8% | 122,600 | -32.7% | 1.17% | -24.3% |
| CI | Sell | CIGNA CORP | $7,807,000 | -21.4% | 45,938 | -22.5% | 0.87% | -19.8% |
| NVRO | Sell | NEVRO CORP | $6,707,000 | -20.6% | 84,000 | -13.8% | 0.75% | -19.0% |
| VRAY | Sell | VIEWRAY INC | $6,685,000 | -8.8% | 966,064 | -15.2% | 0.75% | -7.1% |
| EW | Sell | EDWARDS LIFESCIENCE | $5,948,000 | -67.2% | 40,860 | -68.6% | 0.66% | -66.5% |
| ABT | Sell | ABBOTT LABS | $5,727,000 | -67.5% | 93,899 | -68.1% | 0.64% | -66.9% |
| PTCT | Sell | PTC THERAPEUTICS I | $4,583,000 | -61.3% | 135,884 | -69.0% | 0.51% | -60.6% |
| MASI | Sell | MASIMO CORP | $4,121,000 | -35.6% | 42,201 | -42.0% | 0.46% | -34.3% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $3,595,000 | -65.8% | 73,614 | -25.6% | 0.40% | -65.1% |
| FIXX | Sell | HOMOLOGY MEDICINES | $2,927,000 | -30.4% | 143,487 | -36.2% | 0.33% | -29.1% |
| CELG | Sell | CELGENE CORP | $1,843,000 | -93.3% | 23,212 | -92.4% | 0.21% | -93.1% |
| ZLAB | Sell | ZAI LAB LTDadr | $1,132,000 | +6.9% | 48,668 | -1.8% | 0.13% | +9.5% |
| RDY | Sell | DR REDDYS LABS LTDadr | $695,000 | -16.6% | 21,597 | -15.3% | 0.08% | -14.3% |
| ARAY | Exit | ACCURAY INC | $0 | – | -384,547 | -100.0% | -0.21% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -22,120 | -100.0% | -0.30% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS | $0 | – | -264,699 | -100.0% | -0.53% | – |
| IART | Exit | INTEGRA LIFESCIENCE | $0 | – | -123,198 | -100.0% | -0.75% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS | $0 | – | -41,915 | -100.0% | -0.75% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES | $0 | – | -111,402 | -100.0% | -1.01% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -329,199 | -100.0% | -1.11% | – |
| TSRO | Exit | TESARO INC | $0 | – | -225,260 | -100.0% | -1.41% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS | $0 | – | -783,424 | -100.0% | -1.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
| DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
| PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
| GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
| VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
| INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
| AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
| PFIZER INC | 38 | Q2 2024 | 6.3% |
| MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
| MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
| Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.